Circadian pattern of arrythmic death in patients receiving encainide, Flecainide or moricizine in the cardiac arrhythmia
Open Access
- 1 February 1994
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 23 (2) , 283-289
- https://doi.org/10.1016/0735-1097(94)90408-1
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Effect of the Antiarrhythmic Agent Moricizine on Survival after Myocardial InfarctionNew England Journal of Medicine, 1992
- Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or PlaceboNew England Journal of Medicine, 1991
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- Differing circadian patterns of symptom onset in subgroups of patients with acute myocardial infarction.Circulation, 1989
- Propranolol and the morning increase in the frequency of sudden cardiac death (BHAT study)The American Journal of Cardiology, 1989
- CIRCADIAN VARIATION OF TOTAL ISCHAEMIC BURDEN AND ITS ALTERATION WITH ANTI-ANGINAL AGENTSThe Lancet, 1988
- Circadian variation in the incidence of sudden cardiac death in the framingham heart study populationThe American Journal of Cardiology, 1987
- Circadian variation of transient myocardial ischemia in patients with coronary artery disease.Circulation, 1987
- Circadian variation in the frequency of sudden cardiac death.Circulation, 1987
- Circadian Variation in the Frequency of Onset of Acute Myocardial InfarctionNew England Journal of Medicine, 1985